MIRA Pharmaceuticals, Inc. Common Stock (NASDAQ: MIRA) — Healthcare · Share Price, Chart & Market Data
About: MIRA Pharmaceuticals, Inc. operates as a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a range of neurologic and neuropsychiatric disorders. The company holds exclusive U.S., Canadian, and Mexican rights for Ketamir-2, a patent pending oral ketamine analog under investigation to deliver ultra-rapid antidepressant effects for individuals battling treatment-resistant depression, major depressive disorder with suicidal ideation, and post-traumatic stress disorder. In addition, its oral pharmaceutical marijuana, MIRA-55, is under investigation for treating adult patients suffering from anxiety and cognitive decline, often associated with early-stage dementia. The company was formerly known as MIRA1a Therapeutics, Inc. MIRA Pharmaceuticals, Inc. was incorporated in 2020 and is based in Miami, Florida.
Sector: Healthcare
Industry: Drug Manufacturers - General
Latest price: $1.05 (-0.48%)
MIRAMIRA Pharmaceuticals, Inc. Common Stock
Loading watchlist status…
Trade MIRA now
MIRA Pharmaceuticals, Inc. Common Stock share price
MIRA price activity
Last Price
Change (24hr)
USD (%)
Volume
Volume (4w avg)
Previous Close
N/A
Last Trade
Delayed
27 Apr, 7:31 am GMT+0
MIRA price performance
-6.696%
5D
-0.476%
1M
-29.866%
YTD
5.131%
1Y
MIRA price fundamentals
N/A
Shares Issued
N/A
Dividends Per Share (DPS)
N/A
Earnings Per Share (EPS)
N/A
P/E Ratio
Price market cap
Market cap
N/A
NASDAQ rank
N/A
Sector Rank
N/A
Delayed
27 Apr, 7:31 am GMT+0
MIRA details
MIRA Market Signals